Y Intercept Hong Kong Ltd Purchases Shares of 54,293 Henry Schein, Inc. (NASDAQ:HSIC)

Y Intercept Hong Kong Ltd bought a new stake in Henry Schein, Inc. (NASDAQ:HSIC - Free Report) during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The fund bought 54,293 shares of the company's stock, valued at approximately $3,719,000.

Several other institutional investors and hedge funds also recently bought and sold shares of the company. Farther Finance Advisors LLC lifted its position in shares of Henry Schein by 237.3% during the first quarter. Farther Finance Advisors LLC now owns 2,698 shares of the company's stock worth $186,000 after purchasing an additional 1,898 shares in the last quarter. State of Alaska Department of Revenue increased its stake in shares of Henry Schein by 2.8% during the first quarter. State of Alaska Department of Revenue now owns 14,611 shares of the company's stock worth $1,000,000 after buying an additional 395 shares during the period. Oppenheimer Asset Management Inc. increased its stake in shares of Henry Schein by 5.2% during the first quarter. Oppenheimer Asset Management Inc. now owns 13,745 shares of the company's stock worth $941,000 after buying an additional 678 shares during the period. GAMMA Investing LLC increased its stake in shares of Henry Schein by 37.8% during the first quarter. GAMMA Investing LLC now owns 3,939 shares of the company's stock worth $270,000 after buying an additional 1,081 shares during the period. Finally, Wellington Management Group LLP increased its stake in shares of Henry Schein by 12.6% during the fourth quarter. Wellington Management Group LLP now owns 6,902 shares of the company's stock worth $478,000 after buying an additional 775 shares during the period. 96.62% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several equities research analysts recently weighed in on HSIC shares. Evercore ISI boosted their target price on Henry Schein from $72.00 to $78.00 and gave the stock an "in-line" rating in a research note on Wednesday, July 9th. Wall Street Zen cut Henry Schein from a "buy" rating to a "hold" rating in a research note on Thursday, April 17th. Piper Sandler decreased their target price on Henry Schein from $83.00 to $77.00 and set an "overweight" rating for the company in a research note on Wednesday, April 30th. Barrington Research decreased their target price on Henry Schein from $90.00 to $86.00 and set an "outperform" rating for the company in a research note on Tuesday, May 6th. Finally, Robert W. Baird restated a "neutral" rating and set a $72.00 target price (down previously from $82.00) on shares of Henry Schein in a research note on Monday, July 14th. Nine equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. According to data from MarketBeat, Henry Schein currently has a consensus rating of "Hold" and a consensus target price of $78.08.

Henry Schein Stock Performance

HSIC traded down $1.15 on Friday, hitting $71.47. 827,464 shares of the company traded hands, compared to its average volume of 1,713,737. The company has a 50 day moving average of $71.92 and a 200-day moving average of $71.38. The company has a quick ratio of 0.75, a current ratio of 1.38 and a debt-to-equity ratio of 0.50. The stock has a market capitalization of $8.70 billion, a PE ratio of 22.34, a PEG ratio of 2.40 and a beta of 0.87. Henry Schein, Inc. has a 12-month low of $60.56 and a 12-month high of $82.49.

Henry Schein (NASDAQ:HSIC - Get Free Report) last announced its quarterly earnings data on Monday, May 5th. The company reported $1.15 earnings per share for the quarter, beating analysts' consensus estimates of $1.11 by $0.04. Henry Schein had a return on equity of 14.87% and a net margin of 3.21%. The company had revenue of $3.17 billion for the quarter, compared to analyst estimates of $3.24 billion. During the same quarter in the previous year, the company earned $1.10 EPS. The firm's revenue for the quarter was down .1% compared to the same quarter last year. Sell-side analysts anticipate that Henry Schein, Inc. will post 4.74 earnings per share for the current year.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.